Clik here to view.
Competitor Collaborations in the U.S. During COVID-19
U.S. companies may see opportunities to increase collaborations amongst one another during the current pandemic, but should be aware that they are still subject to the antitrust laws. Read the Alert...
View ArticleClik here to view.
Collaboration, License and other Commercial Agreements: Key Considerations...
The COVID-19 pandemic is continuing to cause major global disruption to the activities of development stage and other life sciences companies due to, among other factors, limited or no access to...
View ArticleClik here to view.
Chinese Cross Border Life Sciences Strategic Transactions in the Age of COVID-19
Increasingly in China over the past decade, corporations in the pharmaceutical, biotechnology and medical device sectors have supplemented their own internal research and development and business...
View ArticleClik here to view.
Territorial Licensing in Collaboration Agreements
Life sciences companies often turn to geographical licensing to realise the maximum value from their assets, and to ensure their products reach markets worldwide, particularly where they do not have a...
View ArticleClik here to view.
Tensions in University Start-up Life Science Licensing Agreements
University tech transfer offices (TTOs) and venture capital firms (VCs) work closely together to advance certain technologies and discoveries from the lab to the market. However, because there are...
View Article
